Retrospective non-interventional study to evaluate safety and efficacy of NOVOCART® Inject in patients with full-thickness cartilage defects in the knee joint.
Retrospective and multicenter non-interventional study to evaluate safety and efficacy of NOVOCART® Inject in patients with localized full-thickness cartilage defects in the knee joint. Safety: Measuring the number of adverse drug reactions/serious adverse drug reactions since treatment and up to the present time. Efficacy: Evaluate symptoms and functional status at the present time using IKDC 2000 (International Knee Documentation Committee) and KOOS (Knee injury osteoarthritis outcome score).
Study Type
OBSERVATIONAL
Enrollment
245
Hochtaunus-Kliniken gGmbH Krankenhaus Bad Homburg
Bad Homburg, Germany
Gelenk-Klinik Gundelfingen
Gundelfingen, Germany
Orthopädische Praxisklinik im Zentrum
Kelkheim, Germany
Orthopädische Klinik Markgröningen gGmbH
Markgröningen, Germany
Number of adverse drug reaction/serious adverse drug reaction
Number of adverse drug reaction/serious adverse drug reaction as a measurement of safety
Time frame: Up to 24 months
Outcome of IKDC 2000
Outcome of the IKDC 2000 as measurements of symptoms and function
Time frame: Up to 24 months
Outcome of KOOS
Outcome of KOOS as measurements of symptoms and function
Time frame: Up to 24 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Dr. med. Michael Moraldo, Dr. med. Sebastian Lauber
Münster, Germany
Nordwest-Krankenhaus Sanderbusch gGmbH
Sande, Germany
Muldentalkliniken GmbH Krankenhaus Wurzen
Wurzen, Germany